Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women between 18 and 42 years old
- People who have been diagnosed with Polycystic Ovary Syndrome (PCOS) based on a specific set of medical guidelines known as the Rotterdam 2003 criteria (confirm with trial site)
- People who have had fewer than three previous frozen embryo transfer (FET) cycles that did not result in pregnancy
- People whose embryo transfer involved no more than two early-stage embryos (cleavage embryos), or one good-quality blastocyst (a more developed embryo), or no more than two poor-quality blastocysts
- People who agree to take part in the study
Who may not be able to join:
- People who have an allergy or a medical reason that prevents them from safely taking hormone medications — for example, a history of breast cancer or blood clotting disorders
- People whose embryo transfer cycle requires genetic testing of the embryo before it is transferred (preimplantation genetic testing)
- People using donor eggs rather than their own
- People who have untreated conditions affecting the uterus or surrounding structures — for example, scar tissue inside the uterus, an unusually shaped uterus, large fibroids (5 cm or bigger), adenomyosis, uterine polyps, or blocked fallopian tubes with fluid build-up (hydrosalpinx)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Lan N Vuong, MD, PhD, University of Medicine and Pharmacy at Ho Chi Minh City
Phone: +84935843336
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Live birth rates after the one embryo transfer
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.